HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
    • Archived Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / HEOR Feature / Article Covers Range of Opinions on Remdesivir Pricing

Article Covers Range of Opinions on Remdesivir Pricing

A recent STAT article offers the opinions of several experts on how much Gilead’s COVID-19 treatment, remdesivir, should cost.

While ReVision Therapeutics’ Paul Fehlner suggests the treatment should cost less than a movie ticket, Northwestern University’s Kellogg School of Management Department of Health Care Director Craig Garthwaite says “it’s impossible to overpay for a truly effective drug.”

“If, at the margin, we slightly overpay for the drug and that makes even one more company move one more set of scientists to think about the problem of Covid-19 and that leads to a better drug, you almost can’t put a price on that,” he tells STAT.

To read the full article on STAT, click here.



You might also be interested in:

  • Patient Drug Costs Increased as Health Plans Promote… 08/07/2020
  • What Does $11M in Donations to Congress Buy Pharma? 08/12/2020
  • Stanford Center for Health Education Launches Online Program… 08/11/2020
  • [Webinar] How can VA/HTA Inform Policy Interventions and… 10/15/2020
  • ICER Outlines Alternative Models for Judging Price of COVID-19… 05/10/2020
  • State Treasurers Call Out Gilead for Putting Remdesivir… 09/21/2020
  • Remdesivir Effective and Profitable for Gilead – And Controversial 02/10/2021

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters

Syndicated Reports

Artificial Intelligence in Healthcare Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Component, Application, End User, and Geography

Healthcare Trends & Forecasts in 2021: Performance Expectations for the Healthcare Industry

Medical Affairs Outsourcing Market 2021 Overview, Trends, Size, Growth and 2028 Future Insights

Bioinformatics Market Research Report by Product, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19

White Papers

What to Look for in an Informatics Platform for Life Sciences R&D

Beyond The Field: Evolving Field Medical Engagement And Talent For The Future

Innovating the Delivery of Patient Support: Branded Patient Support programs for Today’s Health Consumer

Healthcare Cost Containment: Best Practices & Recommendations

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
    • Archived Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute